METHODS AND COMPOSITIONS FOR THE TREATMENT OF DISEASES OF THE EYE
Methods and compositions for prophylaxis and/or treatment of diseases of the eye of a patient resulting angiogenesis in the eye using antagonists of the integrin receptors alphav beta3 and/or alphav beta5. The compositions can be nanoparticles and are administered to the eye by injection into the sc...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; por |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | JUTTA HAUNSCHILD ULRICH LANG MARTIN FRIEDLANDER HANS-MARKUS BENDER MATTHIAS WIESNER |
| description | Methods and compositions for prophylaxis and/or treatment of diseases of the eye of a patient resulting angiogenesis in the eye using antagonists of the integrin receptors alphav beta3 and/or alphav beta5. The compositions can be nanoparticles and are administered to the eye by injection into the sclera of the eye. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_PT1381382EE</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>PT1381382EE</sourcerecordid><originalsourceid>FETCH-epo_espacenet_PT1381382EE3</originalsourceid><addsrcrecordid>eNrjZHD0dQ3x8HcJVnD0c1Fw9vcN8A_2DPH09wtWcPMPUgjxcFUICXJ1DPF19QtR8HdTcPEMdnUMdg0GsUGSrpGuPAysaYk5xam8UJqbQcHNNcTZQze1ID8-tbggMTk1L7UkPiDE0NgCiIxcXY2JUAIAeEcqmw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>METHODS AND COMPOSITIONS FOR THE TREATMENT OF DISEASES OF THE EYE</title><source>esp@cenet</source><creator>JUTTA HAUNSCHILD ; ULRICH LANG ; MARTIN FRIEDLANDER ; HANS-MARKUS BENDER ; MATTHIAS WIESNER</creator><creatorcontrib>JUTTA HAUNSCHILD ; ULRICH LANG ; MARTIN FRIEDLANDER ; HANS-MARKUS BENDER ; MATTHIAS WIESNER</creatorcontrib><description>Methods and compositions for prophylaxis and/or treatment of diseases of the eye of a patient resulting angiogenesis in the eye using antagonists of the integrin receptors alphav beta3 and/or alphav beta5. The compositions can be nanoparticles and are administered to the eye by injection into the sclera of the eye.</description><language>eng ; por</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2009</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20090303&DB=EPODOC&CC=PT&NR=1381382E$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25568,76551</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20090303&DB=EPODOC&CC=PT&NR=1381382E$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>JUTTA HAUNSCHILD</creatorcontrib><creatorcontrib>ULRICH LANG</creatorcontrib><creatorcontrib>MARTIN FRIEDLANDER</creatorcontrib><creatorcontrib>HANS-MARKUS BENDER</creatorcontrib><creatorcontrib>MATTHIAS WIESNER</creatorcontrib><title>METHODS AND COMPOSITIONS FOR THE TREATMENT OF DISEASES OF THE EYE</title><description>Methods and compositions for prophylaxis and/or treatment of diseases of the eye of a patient resulting angiogenesis in the eye using antagonists of the integrin receptors alphav beta3 and/or alphav beta5. The compositions can be nanoparticles and are administered to the eye by injection into the sclera of the eye.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2009</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHD0dQ3x8HcJVnD0c1Fw9vcN8A_2DPH09wtWcPMPUgjxcFUICXJ1DPF19QtR8HdTcPEMdnUMdg0GsUGSrpGuPAysaYk5xam8UJqbQcHNNcTZQze1ID8-tbggMTk1L7UkPiDE0NgCiIxcXY2JUAIAeEcqmw</recordid><startdate>20090303</startdate><enddate>20090303</enddate><creator>JUTTA HAUNSCHILD</creator><creator>ULRICH LANG</creator><creator>MARTIN FRIEDLANDER</creator><creator>HANS-MARKUS BENDER</creator><creator>MATTHIAS WIESNER</creator><scope>EVB</scope></search><sort><creationdate>20090303</creationdate><title>METHODS AND COMPOSITIONS FOR THE TREATMENT OF DISEASES OF THE EYE</title><author>JUTTA HAUNSCHILD ; ULRICH LANG ; MARTIN FRIEDLANDER ; HANS-MARKUS BENDER ; MATTHIAS WIESNER</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_PT1381382EE3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; por</language><creationdate>2009</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>JUTTA HAUNSCHILD</creatorcontrib><creatorcontrib>ULRICH LANG</creatorcontrib><creatorcontrib>MARTIN FRIEDLANDER</creatorcontrib><creatorcontrib>HANS-MARKUS BENDER</creatorcontrib><creatorcontrib>MATTHIAS WIESNER</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>JUTTA HAUNSCHILD</au><au>ULRICH LANG</au><au>MARTIN FRIEDLANDER</au><au>HANS-MARKUS BENDER</au><au>MATTHIAS WIESNER</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>METHODS AND COMPOSITIONS FOR THE TREATMENT OF DISEASES OF THE EYE</title><date>2009-03-03</date><risdate>2009</risdate><abstract>Methods and compositions for prophylaxis and/or treatment of diseases of the eye of a patient resulting angiogenesis in the eye using antagonists of the integrin receptors alphav beta3 and/or alphav beta5. The compositions can be nanoparticles and are administered to the eye by injection into the sclera of the eye.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; por |
| recordid | cdi_epo_espacenet_PT1381382EE |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | METHODS AND COMPOSITIONS FOR THE TREATMENT OF DISEASES OF THE EYE |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T12%3A17%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=JUTTA%20HAUNSCHILD&rft.date=2009-03-03&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EPT1381382EE%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |